Skip to main content
MMSI $86.29 -0.40%
MMSI logo
MMSI · Merit Medical Systems Inc
Track MMSI — free
Market Cap
$5.19B
Shares
59.92M
Volume · Nov 16 61K Avg daily vol (3M) 669.51K
All webcasts

Earnings call · FY2026 Q3

Merit Medical Systems Inc (MMSI) Q3 2026 Earnings Call

Concluded Oct 29, 2026
Oct 29, 2026
Period
FY2026 Q3
Runtime
—
Sources
2 artifacts
Revenue $416.24M +8.4% YoY
Diluted EPS $0.70 +52.2% YoY
Gross margin 48.2% -0.3 pp YoY
Net income $42.31M +52.4% YoY
Open full screen 8-K 10-Q

Executive readout · one minute

What the filings say

8-K earnings release · filed Oct 29, 2026
Merit Medical Systems, Inc. reported third-quarter revenue of $416.2 million, up 8.4%, with 9% organic constant-currency growth, and raised 2026 guidance. It also acquired Solo Pace on October 13, 2026 for approximately $45 million in cash.
10-Q report · filed Oct 29, 2026
Merit reported nine-month sales of $1,217.0 million, up 8.5%, and net income of $122.1 million versus $90.5 million; third-quarter sales rose 8.4% to $416.2 million, and cash, cash equivalents and restricted cash totaled $505.8 million.

The audio replay and transcript follow the call.

Forward guidance

5 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Oct 29, 2026.

Metric Guided
2026 Net Sales Guidance - % Change from Prior Year (GAAP) table Raised
2026
7.9% – 8.4%
2026 Net Sales Guidance - % Change from Prior Year (Constant Cur table Raised
2026
7% – 7.5%
Total Revenue Maintained
Year Ending December 31, 2026
$1.64B – $1.64B
Non-GAAP Earnings Per Share(1) Raised
Year Ending December 31, 2026
$4.33 – $4.37
Non-GAAP Earnings Per Share(1)
Year Ending December 31, 2026
13% – 14%

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Foundational$275.74M +5.7% YoY
Therapeutic Vascular Intervention$35.81M +8.3% YoY
Therapeutic Cardiac Therapies$27.55M +7.9% YoY
Foundational Procedural Solutions$27.16M -15.9% YoY
Therapeutic Endoscopy$23.43M +32.9% YoY
Therapeutic Renal Therapies$13.55M -1.9% YoY
Therapeutic Original Equipment Manufacturer$13.09M +31.5% YoY
Full-screen source Call document